Recombinant humanised anti-PD-1 monoclonal antibody (JS001) treatment for patients with refractory or metastatic nasopharyngeal carcinoma: preliminary results of an open-label, phase 1b/2, clinical study
Titel:
Recombinant humanised anti-PD-1 monoclonal antibody (JS001) treatment for patients with refractory or metastatic nasopharyngeal carcinoma: preliminary results of an open-label, phase 1b/2, clinical study
Auteur:
Xu, Ruihua Wang, Fenghua Li, Qi Shi, Jianhua Shen, Lin Zhang, Qingyuan Yuan, Xianglin Jiang, Yi Xu, Nong Chen, Ye Hu, Xichun Lin, Xiaoyan Yang, Shujun Ren, Chao